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Abstract
Background: The present experiment examined the responses of peripheral modulators and
indices of brain serotonin (5-HT) and dopamine (DA) function and their association with
perception of effort during prolonged exercise in the heat after creatine (Cr) supplementation.
Methods:  Twenty one endurance-trained males performed, in a double-blind fashion, two
constant-load exercise tests to exhaustion at 63 ± 5%  O2 max in the heat (ambient temperature:
30.3 ± 0.5 °C, relative humidity: 70 ± 2%) before and after 7 days of Cr (20 g·d-1 Cr + 140 g·d-1
glucose polymer) or placebo (Plc) (160 g·d-1 glucose polymer) supplementation.
Results: 3-way interaction has shown that Cr supplementation reduced rectal temperature, heart
rate, ratings of perceived leg fatigue (P < 0.05), plasma free-tryptophan (Trp) (P < 0.01) and free-
Trp:tyrosine ratio (P < 0.01) but did not influence the ratio of free-Trp:large neutral amino acids
or contribute in improving endurance performance (Plc group, n = 10: 50.4 ± 8.4 min vs. 51.2 ± 8.0
min, P > 0.05; Cr group, n = 11: 47.0 ± 4.7 min vs. 49.7 ± 7.5 min, P > 0.05). However, after dividing
the participants into "responders" and "non-responders" to Cr, based on their intramuscular Cr
uptake, performance was higher in the "responders" relative to "non-responders" group (51.7 ±
7.4 min vs.47.3 ± 4.9 min, p < 0.05).
Conclusion: although Cr influenced key modulators of brain 5-HT and DA function and reduced
various thermophysiological parameters which all may have contributed to the reduced effort
perception during exercise in the heat, performance was improved only in the "responders" to Cr
supplementation. The present results may also suggest the demanding of the pre-experimental
identification of the participants into "responders" and "non-responders" to Cr supplementation
before performing the main experimentation. Otherwise, the possibility of the type II error may be
enhanced.
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Background
It is well established that perception of effort is elevated
and exercise performance is markedly impaired in hot
environments but the precise mechanism(s) of fatigue
have yet to be determined [1]. The previous observation of
the maintenance of carbohydrate reserves at exhaustion
[2] in conjunction with no impairment in the capacity of
skeletal muscle to generate force during exercise with
hyperthermia [3] may preclude peripheral factors as the
main cause of fatigue during exercise in the heat. Previ-
ously, Nielsen and colleagues [4] proposed a core temper-
ature increase to approximately 39.6°C as a critical factor
in the reduction of central neural motivation and exercise
performance. In subsequent studies, it was proposed that
fatigue during exercise in the heat may occur at a critical
brain temperature, through a reduction in cerebral blood
flow [5,6] and brain glucose levels [7,8]. However, the
exact mechanism(s) for these hyperthermia-induced
effects and/or how thermal stress may affect brain neuro-
transmission during exercise in the heat are presently
unknown.
Several studies have attributed the changes in body tem-
perature [e.g., [9,10]], the higher effort perception and
impaired exercise tolerance during exercise in the heat to
events localized within the central nervous system, and in
particular, the serotonergic and dopaminergic systems
[11-13]. Soares et al. [12,13] for example, suggested that
core body temperature was elevated and exercise perform-
ance was diminished following pre-exercise intracerebrov-
enticular injection of tryptohan (Trp: i.e. a 5-HT
precursor) in rats. Lin et al. [10] also observed that when
hypothalamic serotonin (5-HT) levels were increased in
the rat by administration of Fluoxetine (i.e. 5-HT reuptake
inhibitor) and 5-hydoxytryptophan (i.e. a 5-HT precur-
sor) there was an increase in metabolic heat production
with a concomitant reduction in heat loss. In addition,
Bridge et al. [14], using a combined Buspirone (i.e. 5-HT1A
agonists/dopamine D2 antagonist) and Pindolol (5-HT1A
antagonist) neuroendocrine challenge, found the
dopaminergic-induced prolactin (Prl) response to be sig-
nificantly correlated both with submaximal exercise dura-
tion at 35°C, rectal temperature and the rate of
temperature rise. They concluded that high activity of the
dopaminergic pathways in the hypothalamus was a pre-
dictor of exercise tolerance in the heat. More recently,
Watson et al., [15] examined the effect of the dual
dopamine/noradrenaline reuptake inhibitor (bupropion)
on performance, thermoregulation and hormonal
responses during exercise in the heat (30°C) and in tem-
perate (18°C) conditions. They found that although per-
ception of effort and thermal stress were not different
between bupropion and placebo trails during exercise in
the heat, exercise performance was enhanced by acute
bupropion administration. No such effect was seen at
temperate conditions. These authors suggested that
bupropion may diminish inhibitory signals arising from
the CNS to discontinue exercise due to hyperthermia ena-
bling participants to increase performance.
Creatine (Cr) is abundant in muscles and the brain and
after phosphorylation used as an energy source for adeno-
sine triphosphate synthesis [16]. Cr for example, was
found to improve performance during high intensity exer-
cise by increasing intramuscular Cr and phosphocreatine
(PCr) levels [17] and by accelerating the resynthesis rate of
PCr [18]. However, although the role of Cr in protecting
muscle fatigue during high intensity exercise was exten-
sively studied and understood, its role in preventing ther-
mal-stress and central fatigue developments was not. Cr
for example, has been shown to elevate total body water
(TBW) [19,20], enhance body thermal tolerance, reduce
core temperature and heart rate and improve performance
during exercise in the heat [21]. However, whether these
effects of Cr on thermoregulation and exercise perform-
ance were due to better maintenance of increase TBW or
central neural effects is presently unknown. It was found
for example, that oral Cr supplementation improved
mental function and reduced mental fatigue by increasing
the oxygen utilization in the brain [16]. In addition, sev-
eral pharmacological studies suggested that oral Cr sup-
plementation has been found to increase brain DA
synthesis in the substantia nigra of mice by protecting
against striatal dopamine depletion [22] and/or by
enhancing tyrosine hydroxylase activation (the rate-limit-
ing enzyme of brain DA biosynthesis) [23,24]. However,
no studies were examined so far the responses of periph-
eral modulators and indices of brain 5-HT and DA func-
tion during exercise in the heat after Cr supplementation,
The purpose therefore of the present experiment was to
examine the effects of oral Cr, used as a physiological
model to enhance body thermal tolerance, on perceptual
responses and on central fatigue development by measur-
ing peripheral modulators and indices of brain 5-HT and
DA metabolic interaction during exercise in the heat in
trained humans.
Methods
Participants
Twenty one endurance-trained males volunteers (Table 1)
provided written informed consent for the study, which
was approved by the Glasgow University Research Ethical
Committee. Participants were recruited from local athlet-
ics and cycling clubs and none were acclimatized to exer-
cise in the heat. Participants eligibility was initially
assessed by interview. No participant had a history of car-
diovascular or respiratory disease and/or evidence of mus-
culoskeletal injury. All participants were Cr free for at least
8 weeks prior to the study. The investigators did not reveal
prior to interview that participants would be excluded ifJournal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
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they had supplemented with Cr in the 8 weeks preceding
the study. One participant from the placebo (Plc) group
had previously supplemented with Cr. No Cr was detected
in the baseline urine samples of any participant.
Experimental design
Participants initially underwent a continuous incremental
test to volitional exhaustion in order to determine the lac-
tate threshold (LT), maximum oxygen consumption ( O2
max) and the maximal work rate (WRmax). Following the
maximal incremental exercise test, participants visited the
laboratory on at least two separate occasions in order to
become familiar with the exercise protocol and experimen-
tal procedures, in addition to establishing a suitable work
rate (WR) that would elicit fatigue in 40–60 min. This was
achieved by setting the WR at 20% Δ (i.e., 20% of the dif-
ference between the  O2 at the LT and  O2 max) during the
initial familiarization session and, where necessary, adjust-
ing the WR for subsequent trials to achieve the desired
duration. This intensity of exercise was chosen to avoid
fatigue occurring as a result of muscle glycogen depletion
[2]. Following the familiarization period (at least two
familiarization trails were carried out identical to the exper-
imental trails with exception of complete blood collec-
tions), participants were matched for body mass and were
randomized, in a double-blind fashion, to receive either Cr
or Plc trials. Participants performed one constant-load exer-
cise test to volitional exhaustion pre-supplementation and
one post-supplementation. The first test was conducted at
least 48 hrs after the final familiarization trial. The supple-
mentation period for both groups started on the day after
the first test and finished the day before the second test.
Supplementation protocol
Cr supplementation (Creatamax 300, Maximuscle Ltd.,
Watford, UK) consisted of 22.8 g·d-1 Cr·H2O (equivalent
to 5 g Cr × 4 daily) and 35 g of glucose polymer (Maxim,
Geffen, Holland) made up in 500 mls of warm to hot
water for 7 days taken at equal intervals throughout the
day. This protocol has been shown to increase resting
muscle PCr levels within 5 days [17]. Each supplementa-
tion was freshly made prior to consumption in order to
prevent any degredation of Cr to creatinine (Crn). The Plc
group consumed 160 g·d-1 of glucose polymer (40 g × 4
daily) for 7 days, prepared and administered in an identi-
cal fashion to the Cr supplement. Both supplements had
similar taste, texture and appearance and were placed in
generic packets to ensure double-blind administration.
Participants otherwise followed their normal diet but
eliminated caffeine and caffeine-containing foods
throughout the experimental period to minimize the pos-
sible inhibitory effects of caffeine on the ergogenic effect
of Cr. At the end of the study all participants gave verbal
assurance that they had complied with these instructions.
Procedures
All exercise tests were carried out between 18:00 and
20:00 hr. Participants reported to the laboratory on the
day of testing after a standardized meal and having
refrained from alcohol and strenuous exercise the day
before. The participant's left hand and forearm were
immersed in water at 42–44°C for fifteen minutes in
order to allow for arterialization of the venous blood [25].
Following this, a 21 G cannula was introduced into a
superficial vein on the dorsal surface of the heated hand
and a resting blood sample (10 ml) obtained. The venous
cannula was kept patent by a slow (c. 0.5 ml·min-1) infu-
sion of isotonic saline between samples. The participant
was transferred to the climatic chamber (ambient temper-
ature of 30.3 ± 0.5°C with a relative humidity of 70 ± 2%
and air velocity of approximately 3.6 m·sec-1) and
remained seated on the cycle ergometer for a further 5
min. Participants were then instructed to begin 5 min of
unloaded cycling before another blood sample was
obtained. After 5 min of unloaded cycling, the WR was
increased in a "single step" to the predetermined WR and
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Table 1: Physical characteristics of the two groups of participants. Values are presented as the mean ± SD
Placebo Group (n = 10) Creatine Group (n = 11)
Pre Post Pre Post
Age (yr) 27 ± 4 - 27 ± 5 -
Height (cm) 181 ± 4 - 178 ± 7 -
Weight (kg) 71.0 ± 6.0 71.2 ± 6.0 72.7 ± 6.6 73.4 ± 6.6*
Total body water (L) 40.4 ± 3.3 40.5 ± 3.2 41.0 ± 3.1 41.6 ± 3.2*
Intracellular Water (L) 21.9 ± 1.8 21.9 ± 1.8 22.2 ± 1.8 22.7 ±
Extracellular Water (L) 18.5 ± 1.5 18.5 ± 1.4 18.8 ± 1.4 18.9 ± 1.5
O2 max (L·min-1)
4.3 ± 0.4 - 4.5 ± 0.4 -
O2 max (ml·kg·min-1)
60.5 ± 4.7 - 61.4 ± 4.6 -
Max work rate (watts) 350 ± 34 - 373 ± 31 -
* Indicates a significant difference from pre-supplementation values
 V
 VJournal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
Page 4 of 12
(page number not for citation purposes)
participants maintained a pedal cadence of 60–90 rpm
throughout the test. Participants exercised at the same WR
for both experiments (i.e., 16 ± 11% Δ or 63 ± 5% O2 max,
225 ± 26 watts). Exhaustion was defined as the point at
which the participant could no longer maintain the pedal
cadence above 60 rpm for a second occasion (at around
15 seconds) after an initial verbal warning from the inves-
tigators. Blood samples were obtained at 5 min intervals
throughout exercise and at exhaustion. Time to exhaus-
tion was recorded but withheld from the participant until
all exercise tests had been completed.
Blood treatment and analysis
Blood (10 ml) was drawn into dry syringes and dispensed
into tubes containing K3EDTA and the remainder into
tubes containing no anticoagulant. Duplicate aliquots
(400 μL) of whole blood from the K3EDTA tube were rap-
idly deproteinised in 800 μL of ice cold 0.3 mol·L-1 per-
chloric acid. After centrifugation, the supernatant was
used for the measurement of glucose and lactate using
standard enzymatic methods with spectrophotometric
detection (Mira Plus, ABX Diagnostics, Montpellier,
France). Some of the uncoagulated blood was also used
for the measurement of haemoglobin (Hb) (cyanmethae-
moglobin method, Sigma Chemical Company Ltd., Dor-
set, UK) and packed cell volume (PCV) (conventional
microhematocrit (Hct) method). All blood analyses were
carried out in duplicate with the exception of PCV, which
was analysed in triplicate. Plasma volume changes were
calculated from changes in Hb and PCV relative to initial
baseline values [26]. An aliquot of whole blood from the
K3EDTA tubes was centrifuged and the plasma obtained
was separated and used for the measurement of free fatty
acids (FFA) (colorimetric method, Roche Diagnostics
GmbH, Germany) and concentrations of amino acids
including total and free Trp, tyrosine (Tyr) and large neu-
tral amino acids (LNAA) by HPLC using fluorescence
detection and pre-column derivitisation with 18 o-phtha-
laldehyde (Hypersil Amino acid method, ThermoHyper-
sil-Keystone, Runcorn, UK). The LNAA includes Tyr,
phenylalanine, leucine, isoleucine and valine. Free-Trp
was separated from protein-bound Trp by filtering plasma
through 10,000 NMWL 'nominal molecular weight limit'
cellulose filters (Ultrafree MC filters, Millipore Corpora-
tion, USA) during centrifugation at 5000 g for 60 min at
4°C. Prior to centrifugation, filters were filled with a 95%
O2 – 5% CO2 mixture in order to stabilize pH. The blood
in tubes without anticoagulant was allowed to clot and
then centrifuged; the serum collected was used for the
measurement of prolactin (Prl) by sandwich magnetic
separation assay (Technicon Immuno 1 System, Bayer
Diagnostics, Newbury, UK).
Calculations
The thermal gradient was calculated as rectal temperature
(Trec) – skin temperature (Tsk). The calculation of
weighted mean Tsk [Tsk = 0.3 (Tchest + Tarm) + 0.2 (Tthigh +
Tcalf)] was according to the method of Ramanathan [27].
Mean body temperature (Tb) was calculated at each time
point as 0.87Trec+0.13Tsk [28].
Estimated Cr uptake
Participants completed 8 separate 24 hr urine collections.
The collection began on the day preceding supplementa-
tion (baseline), and then continued through the 7 days of
supplementation. The urine volume for each 24 hr period
was measured and mixed thoroughly, with a representa-
tive 20 mL sample being stored at -20°C for subsequent
analysis (ABX Mira Plus Spectrophotometer, ABX Diag-
nostics, UK) of Cr and Crn concentration, using a spectro-
photometric enzymatic Crn Kit (MPR1 – Kit no. 839434,
Roche Diagnostics Ltd., East Sussex, UK). Estimated Cr
uptake was calculated by subtracting the total Cr excreted,
corrected for Crn excretion, from the total amount supple-
mented per day. Estimated intramuscular [Cr] (mmol·kg-
1·dry weight muscle) was calculated based on an esti-
mated muscle mass amounting to 40% of body mass and
average muscle water approximating 77% of wet weight
[29].
Statistical analysis
Data were expressed as the mean ± SD following a test for
the normality of distribution. For data that violated the
assumptions for parametric analyses (i.e. equality of vari-
ance and normality of distribution) non-parametric anal-
yses was carried out and these data were expressed as the
median (Interquartile range: IQR). Statistical analysis was
carried out using a mixed 3-way ANOVA (Group × Pre-
and Post- supplementation × Time) with repeated meas-
ures on the last two factors. A subsequent 2-way ANOVA
with repeated measures was performed when there was a
main effect on Group, Pre-Post supplementation, or inter-
action. Two-sample t-test (between treatment effect, i.e.,
magnitude of change (Δ) in the Cr group vs. Δ in the Plc
group) and student t-test (within treatment effect, i.e., Pre-
vs. Post-supplementation) were performed if a main treat-
ment or interaction effect was observed. For non-paramet-
ric data, Friedman two-way ANOVA (followed by
Wilcoxon test) and Mann-Whitney tests were used for
paired and unpaired data, respectively. Pearson product
moment r and Spearman rho correlation analyses for par-
ametric and non-parametric data respectively were used to
assess the relationship between selected variables. Corre-
lation analysis was performed for each time point sepa-
rately. Statistical significance was a priori at p < 0.05.
Results
Physiological responses, anthropometrics and 
performance data
Relative to the Plc group, Cr supplementation increased
intracellular water (ICW), TBW and body mass (Table 1)Journal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
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and reduced rectal temperature (Trec), mean body temper-
ature (Tb) (Figure 1), heart rate (HR), sweat rate and rat-
ings of perceived leg fatigue (Figure 2) (3-way interaction;
p < 0.05). However, Cr did not influence skin temperature
(Tskin) (Figure 1), total sweat loss, changes in plasma vol-
ume, blood [glucose] and [lactate],  O2, carbon dioxide
production ( CO2), respiratory exchange ratio (RER),
minute ventilation ( E) and perception of breathlessness
(Figure 2). Endurance performance was not different
between and within Plc group and Cr groups, as a whole
(Plc: 50.4 ± 8.4 min vs. 51.2 ± 8.0 min, p < 0.05; Cr group:
47.0 ± 4.7 min vs. 49.7 ± 7.5 min, p > 0.05). However,
after dividing the participants into "responders" and
"non-responders" to Cr supplementation based on their
intramuscular Cr uptake [29,30], performance increased
in the "responders" relative to "non-responders" to Cr
group (51.7 ± 7.4 min vs.47.3 ± 4.9 min, p < 0.05). Five
out of the eleven participants in the Cr group reported that
they found the post-supplementation trial easier, while
two out of the ten participants in the Plc group rated the
post-supplementation trial to be easier. No side effects
were reported following Cr and/or Plc supplementations.
Estimated Cr uptake
Estimated Cr uptake was calculated by subtracting the total
Cr excreted, corrected for the increase in Crn excretion,
from the total amount supplemented per day. Estimated
intramuscular Cr (mmol·kg-1·dry weight muscle) was cal-
culated based on an estimated muscle mass amounting to
40% of body mass and average muscle water approximat-
ing 77% of wet weight [31]. In the Cr group, Crn excretion
increased from 1.4 ± 0.4 g·day-1 pre-supplementation to
2.4 ± 1.0 g·day-1 on the final day of supplementation.
There was no increase in Crn excretion in the placebo group
(1.5 ± 0.4 g·day-1  to 1.4 ± 0.4 g·day-1). Cr excretion
increased from 8.7 ± 3.7 g·day-1 pre-supplementation to
17.4 ± 1.9 g·day-1; no Cr was detected in the urine of the
placebo group. Estimated Cr uptake was maximal on the
first day of Cr supplementation [10.4 ± 3.7 g, 56 ± 18%
being retained] and was lowest on the final day [2.9 ± 1.9
g, 13 ± 9% being retained]. The total amount of Cr retained
over the supplementation period was 39 ± 14 g, with an
estimated increase in intramuscular Cr of 45 ± 15
mmol·kg-1·dry weight muscle. Based on these estimates, 3
participants were classified as "non-responders" [22 ± 3
mmol·kg-1·dry weight muscle] and the remaining 8 partic-
ipants were classified as "responders" (53 ± 5 mmol·kg-
1·dry weight muscle) as previously described [29].
Plasma amino acids, prolactin and free fatty acids
There were no significant differences between Plc and Cr
groups in plasma total [Trp], [Tyr], [large neutral amino
acids] (LNAA) (Table 2), total [Trp]:[LNAA] ratio, total
[Trp]:[Tyr] ratio, free-[Trp]:LNAA ratio and free-[Trp]:[Tyr]
ratio (Table 3). The Δ plasma total [Trp], [Tyr] and [LNAA]
and the ratios of total [Trp]:[LNAA], total [Trp]:[Tyr] and
free-[Trp]:[LNAA] were also not different between the
groups. However, plasma free-[Trp] was significantly
lower in the post-Cr supplementation trial (χ2 = 33.909,
df = 5, p < 0.01) and in the "responders" (χ2 = 25.786, df
= 5, p < 0.01) when compared to the pre-supplementation
trial (Table 2). The Δ free-[Trp] was also significantly
lower during exercise in the Cr group (χ2 = 15.881, df = 1,
p < 0.05) and in the "responders" (χ2 = 14.582, df = 1, p <
0.05) when compared with Δ Plc group. In "responders",
the plasma free-[Trp]:[Tyr] ratio was significantly lower at
rest and during exercise post-Cr, relative to the pre-supple-
mentation trial, (χ2 = 13.071, df = 5, p < 0.05) (Table 3).
In addition, there was a tendency for Δ free-[Trp]:[Tyr]
ratio to be significantly lower in the "responders" group
when compared with Plc group (p  = 0.071). [LNAA]
(Table 2), free-[Trp]:[LNAA] ratio, total [Trp]:[LNAA]
ratio, and total [Trp]:[Tyr] ratio (Table 3) were not differ-
ent between pre- and post-supplementation trials in both
Plc and Cr groups as well as in the "responders". Plasma
[Prl] was not different between the Plc group and the Cr
group as a whole and between pre- and post-supplemen-
tation trials in both Plc and Cr groups (Table 4). In all tri-
als, [Prl] increased significantly over time when compared
to resting levels. The Δ plasma [Prl] was also not different
between the groups. Plasma [FFA] was not different
between Plc and Cr groups or between pre- and post-Cr
supplementation trials (Table 4).
Correlation analysis
There were no significant correlations between plasma
free-[Trp] and Trec, between free-[Trp] and RPE, between
free-[Trp] and plasma [FFA], between Trec and [Prl], and
between free-[Trp] and [Prl], when examined for each
time-point separately.
Discussion
It has been previously shown that Cr increased water
retention [20], enhanced body thermal tolerance [21] and
improved endurance performance during exercise in the
heat [32] but the mechanism of these Cr-induced effects
have not been extensively studied. In the present experi-
ment Cr was used as a "vehicle" in an attempt to reduce
thermal stress and examine the responses of peripheral
modulators and indices of brain 5-HT and DA function, in
association with effort perception during exercise in the
heat. The significant observations of the present experi-
ment were the effectiveness of Cr to reduce perception of
leg muscular fatigue and lower plasma free-[Trp] and free-
[Trp]:[Tyr] ratio. In addition, although these responses
have not contributed in enhancing endurance perform-
ance in the whole Cr group, after distinguishing the par-
ticipants into "responders" and "non-responders" to Cr
 V
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based on their intramuscular Cr uptake [29] performance
was improved in the "responders" to Cr group (51.7 ± 7.4
min vs. 47.3 ± 4.9 min, p = 0.031). The observation also
that five out of the eight "responders" reported that they
found the post-supplementation trial to be easier and that
these same five participants showed the largest estimated
Rectal temperature (top panel), mean skin temperature (middle panel) and mean body temperature (bottom panel) in the Cr  (left side) and placebo (right side) supplemented groups Figure 1
Rectal temperature (top panel), mean skin temperature (middle panel) and mean body temperature (bottom 
panel) in the Cr (left side) and placebo (right side) supplemented groups. *: indicates a significant difference between 
pre (l) to post (m) supplementation. †: indicates a significant greater change in the Cr group compared with the placebo 
group (p < 0.05). Values are given as mean (SD).
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Cr uptake and performance gains may be a further indica-
tion of the demanding of separating the participants into
"responders" and "non-responders" to Cr supplementa-
tion.
Previous studies have attributed the changes in body tem-
perature [9,10], the higher effort perception and impaired
endurance performance during exercise in the heat to
events localized within the serotonergic and dopaminer-
gic systems [11-14]. Recently, for example, 5-HT precursor
drugs were found to elevate body heat storage by increas-
ing metabolic heat production with a concomitant reduc-
tion in heat loss [10], and subsequently to reduce exercise
performance in the heat [12]. On the other hand, high
hypothalamic dopaminergic activity has been shown to
be a reasonable predictor of exercise tolerance during pro-
longed submaximal exercise in the heat [14]. In the
present experiment, participants who had supplemented
with Cr reported significantly lower thermal stress and rat-
ings of perceived leg fatigue. These may suggest that they
were able to discern the benefit of this putative thermal-
stress reduction strategy.
The increased hydration status, observed in the present
study, seems to be a reasonable contributor to the reduc-
tion in effort perception during exercise in the heat fol-
lowing Cr supplementation. However, the similar plasma
volume and total sweat rate results in association with no
differences in blood metabolites and cardiorespiratory
responses observed between trials may augment the pos-
sibility that the reduction in participantive fatigue is par-
tially due to the lowered plasma free-[Trp] observed in the
Cr group and subsequently to the lower brain 5:HT syn-
thesis. It has been suggested, for example, that a high
brain [5-HT]:[DA] ratio increases effort perception (i.e.
central fatigue) during prolonged exercise while a low [5-
HT]:[DA] ratio may favour increased arousal and central
neural motivation [33]. The role of DA, in protecting
RPE (breathing) (top panel) and RPE (legs) (bottom panel) in the Cr (left side) and placebo (right side) supplemented groups  during exercise Figure 2
RPE (breathing) (top panel) and RPE (legs) (bottom panel) in the Cr (left side) and placebo (right side) supple-
mented groups during exercise. *: indicates a significant difference between pre (l) to post (m) supplementation. Values 
are given as mean (SD).
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against central fatigue development, has also recently
been supported by Watson et al. [15] who found that a
dual dopamine/noradrenaline reuptake inhibitor,
enhanced exercise performance in the heat but not in tem-
perate conditions. In addition, it has been shown that DA
microinjections into the hypothalamus and substantia
nigra of the rat produced hypothermia through an
increase in brain [DA] [34,35]. This notion was recently
supported by Lieberman et al. [36] who observed that L-
Tyr supplementation, used as the primary brain catecho-
lamine precursor, was able to increase brain DA and non-
epinephrine levels contributing to the reduction in body
heat-storage in rats that were exposed in hot environment
(41°C).
Nybo et al. [8] however, found that brain uptake of Trp
and Tyr as well as brain DA release were not affected by
hyperthermia, failing therefore to support the classic "5-
HT-central fatigue hypothesis" [37]; and also the involve-
ment of brain DA function in thermoregulation during
exercise in the heat. They suggested that brain glycogen
depletion may have contributed to central fatigue during
exercise in the heat. However, the results presented by
these authors do not preclude the involvement of modu-
lators of brain 5-HT function in central fatigue since a cor-
relation was found between arterial free-[Trp] and brain
Trp uptake [8]. Brain Trp uptake for example, has been
shown on numerous occasions to be the rate-limiting step
of 5-HT synthesis [38], thus an involvement of 5-HT dur-
ing exercise in the heat as classically proposed cannot be
excluded. It should be noted that brain 5-HT was not
measured in the study by Nybo et al. [8]. Consequently,
the finding of a lower plasma free-Trp:Tyr ratio (and by
extrapolation a lower 5-HT:DA ratio since both precursors
share the same L-system transport across the blood brain
barrier [39]) may have contributed to reducing thermal
stress and to attenuating effort perception following Cr
supplementation. It is noted that no such response was
observed in Plc trials.
On the other hand, it seems to be unreasonable to suggest
that the lower plasma free-[Trp] and free-Trp:Tyr ratio
may have contributed to the improvement in perform-
ance in the "responders" to Cr group. For the reason that
Table 2: Concentrations of total Trp, Tyr, LNAA and free-Trp before and after supplementation. 
Blood collection time (min)
Group Trial Rest 40 End
Total [Trp] (μmol·l-1) Plc Pre 58.3(12) 56.7(22) 63.9(11)
Post 55.2(14) 67.7(22) 75.5(16)§
Cr Pre 47.8(14) 71.1(16)§ 69.9(17)§
Post 53.4(5) 62.3(7)§ 71.7(21)§
Resp Pre 47.5(6) 65.8(15)§ 68.7(18)§
Post 53.6(7) 62.4(8)§ 71.6(20)§
[Tyr] (μmol·l-1) Plc Pre 85.3(18) 94.8(12) 116(24)§
Post 76.9(41) 86.5(33) 104.1(36)
Cr Pre 71.9(37) 111.5(41)§ 121.7(46)§
Post 81.3(34) 104.9(31)§ 112.4(52)§
Resp Pre 70.3(31) 112.1(36)§ 118.3(45)§
Post 74.6(33) 109.8(31)§ 114.5(51)
[LNAA] (μmol·l-1) Plc Pre 831(29) 902(211) 986(254)
Post 873(233) 897(171) 994(375)
Cr Pre 744(334) 1076(340) 945(326)
Post 812(189) 806(372) 933(361)
Resp Pre 732(279) 1051(273) 962(267)
Post 764(187) 864(473) 871(322)
Free-[Trp] (μmol·l-1) Plc Pre 2.5(0.6) 3.1(0.7)§ 3.3(0.8)§
Post 2.6(1.2) 3.2(0.7)§ 3.6(0.9)§
Cr Pre 2.4(0.7) 2.9(0.6)§ 3.5(0.5)§
Post 2.4(0.5) 2.6(0.5)*§ 3.0(0.7)*§
Resp Pre 2.6(0.9) 3.1(0.6) 3.4(0.6)§
Post 2.3(0.7) 2.7(0.6)* 3.0(0.5)*§
Values are given as median (IQR).
* Indicates a significant difference from pre-supplementation values
§ Indicates a significant difference over time compared with the resting value 
Resp: "responders"Journal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
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Table 3: Total Trp:LNAA, total Trp:Tyr, free-Trp:LNAA and free-Trp:Tyr ratios before and after supplementation. 
Blood collection time (min)
Group Trial Rest 40 End
Total [Trp]:[LNAA] ratio Plc Pre .069(.016) .071(.015) .076(.016)
Post .070(.012) .072(.017) .084(.022)
Cr Pre .062(.013) .069(.010) .075(.012)
Post .073(.016) .080(.016) .082(.007)§
Resp Pre .062(.012) .069(.010) .076(.014)
Post .076(.016) .077(.019) .082(.006)§
Total [Trp]:[Tyr] ratio Plc Pre 0.65(.24) 0.61(.09) 0.58(.17)
Post 0.71(.07) 0.68(.18) 0.74(.19)
Cr Pre 0.64(.14) 0.63(.07) 0.61(.15)
Post 0.65(.16) 0.62(.14) 0.65(.09)
Resp Pre 0.66(.20) 0.62(.09) 0.61(.17)
Post 0.71(.16) 0.62(.20) 0.62(.09)
Free-[Trp]:[LNAA] ratio Plc Pre .0030(.0007) .0040(.0010) .0036(.0020)
Post .0031(.0024) .0038(.0014) .0048(.0012)
Cr Pre .0034(.0021) .0032(.0015) .0037(.0016)
Post .0028(.0015) .0038(.0017) .0028(.0027)
Resp Pre .0042(.0020) .0034(.0010) .0045(.0012)
Post .0027(.0015) .0039(.0017) .0043(.0025)
Free-[Trp]:[Tyr] ratio Plc Pre .032(.017) .035(.008) .027(.014)
Post .035(.018) .039(.012) .043(.013)
Cr Pre .034(.027) .032(.013) .027(.012)
Post .028(.016) .028(.013) .024(.019)
Resp Pre .042(.025) .033(.011) .032(.013)
Post .032(.017)* .026(.015)*§ .029(.018)
Values are given as median (IQR).
* Indicates a significant difference from pre-supplementation values
§ Indicates a significant difference over time compared with the resting value
Resp: "responders"
Table 4: Concentrations of plasma prolactin and FFA before and after supplementation. 
Blood collection time (min)
Group Trial Rest 40 End
Plasma [Prolactin] (nmol·l-1) Plc Pre 0.13(.04) 0.51(.38)§ 0.94(.83)§
Post 0.14(.06) 0.53(.24)§ 0.93(.14)§
Cr Pre 0.15(.07) 0.84(.58)§ 1.07(.63)§
Post 0.15(.05) 0.79(.51)§ 1.14(.56)§
Resp Pre 0.15(.04) 1.14(.39)§ 1.27(.44)§
Post 0.14(.04) 0.98(.46)§ 1.39(.36)§
Plasma [FFA] (mmol·l-1) Plc Pre 0.53(0.47) 0.37(0.18) 0.40(0.34)
Post 0.38(0.10) 0.28(0.14) 0.23(0.19)
Cr Pre 0.42(0.26) 0.29(0.11) 0.31(0.18)
Post 0.48(0.27) 0.32(0.14) 0.34(0.18)
Resp Pre 0.48(0.24) 0.28(0.10) 0.30(0.15)
Post 0.42(0.20) 0.29(0.10) 0.32(0.16)
Values are given as median (IQR).
§ Indicates a significant difference over time compared with the resting value
Resp: "responders".Journal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
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plasma free-[Trp] was lower in both "responders" and
"non-responders" but performance was improved only in
the "responders" to Cr group (Table 2). Similarly
although, the plasma free-Trp:Tyr ratio was lower in the
"responders" group this was evident only until the 40 min
time-point and not at exhaustion. It is possible therefore
that Cr is effective in reducing effort perception, through
to a lower plasma free-[Trp], during exercise in the heat in
both "responders" and "non-responders" to Cr loading;
however, for eliciting an endurance performance
improvement different but still unknown mechanism(s)
may play a role. In the current investigation and in most
of the related literature involving humans, only indirect
markers of brain 5-HT and DA function are assessed. Nev-
ertheless, several pharmacological studies, suggested that
oral Cr supplementation increased brain DA synthesis in
the substantia nigra of mice by protecting against striatal
dopamine depletion [22] and/or by enhancing tyrosine
hydroxylase activation (the rate-limiting enzyme of brain
DA biosynthesis) [23,24]. In addition, an improvement in
mental function and diminished central fatigue was
observed during performing a mathematical calculation
following oral Cr supplementation [16]. Consequently,
more controlled studies are warranted to examine the
potential effect of Cr on central fatigue during exercise in
the heat.
Plasma [Prl] was found to be similar in all trials; however,
since no differences observed in plasma [LNAA] and in
the ratio of free and total Trp:LNAA the similar plasma
[Prl] results and the lack of significant correlation between
plasma [Prl] and Trec  were not entirely unexpected.
According to Wurtman [40] for example in order to elicit
a reduction in brain Trp uptake and, therefore, attenua-
tion in brain 5-HT turnover, a 5- to 6-fold elevation in
plasma [LNAA] is required. In addition, Leathwood and
Fernstrom [41] suggested that a 13- to 26- fold elevation
in total Trp:LNAA ratio is required to induce a change in
the brain stem [5-HT] in monkeys. The association how-
ever, between peripheral modulators of brain 5-HT func-
tion and circulating [Prl] during exercise has not been
fully explained. Fischer et al. [42] for example, observed
an increase in [Prl] during exercise in proportion to the
rise in plasma free-[Trp]. Some investigators found a pos-
itive correlation between serum [Prl] and Trec [43,44] dur-
ing exercise in the heat and this relationship has been
used to justify brain monoamine system involvement in
regulating Trec and Prl secretion [11]. Brisson et al. [43,44]
demonstrated that a body-temperature threshold value
had to be reached for heat stress to induce a significant
blood Prl response during active or passive heat exposure.
These authors estimated this mean Trec threshold to be
approximately 1.3°C – 1.7°C above normal body temper-
ature values. In the present experiment, the rise in Trec
induced by exercise in the heat far exceeded this threshold
in both pre- and post-supplementation trials, thus result-
ing in a similar elevation in plasma [Prl] in both Plc and
Cr groups (Table 4). However, Trec was lower in the post-
Cr supplementation trial and Trec and plasma [Prl] were
not correlated. These results are in agreement with a
number of previous studies [e.g., [45]] that showed that
Prl secretion is not always related to plasma free-[Trp] and
this may be more evident during exercise in the heat. Con-
sequently, although Cr was effective in reducing thermal
stress, this reduction was insufficient to significantly alter
plasma [Prl]. However, this finding does not necessarily
preclude a difference in hypothalamic Prl secretion
between Plc and Cr trials.
A number of previous classic studies have reported a sig-
nificant correlation between plasma [FFA] and plasma
free-[Trp] primarily due to FFA displacing Trp from its
binding to albumin [e.g., [46,47]]. In the present experi-
ment, the rise in plasma [FFA] was modest and not differ-
ent between trials but plasma free-[Trp] was lower during
exercise and at exhaustion on the post-Cr supplementa-
tion trial. This somewhat surprising result, in conjunction
with the lack of a significant correlation between plasma
[FFA] and plasma free-[Trp] would suggest a more com-
plex control of plasma free-[Trp] during exercise in the
heat than previously described. Since differences in
plasma volume, which could partially explain the reduc-
tion in plasma free-[Trp] and free-Trp:Tyr ratio were not
observed in the present experiment, the exact mecha-
nism(s) responsible for the observed reduction in plasma
free-[Trp] and free-Trp:Tyr ratio after Cr loading (despite
no difference in plasma [FFA]) and the significance of
these observations remain to be determined.
The major limitations of the experiment were the indirect
method used for classifying the participants into
"responders" and "non-responders" to Cr. However, by
not pre-distinguishing the potential "responders" and
"non-responders" to each particular ergogenic aid supple-
ment, such as Cr treatment, the type II statistical error
might has been elevated. Syrotuik and Bell [48] for exam-
ple, examined the physiological profile of "responders"
and "non-responders" to 5-days Cr loading sub-divided
based on their mean changes in resting muscle Cr + PCr
levels. They found that there were three subdivisions of Cr
supplementation: the "responders", the "quasi-respond-
ers" and the "non-responders" to Cr, subdivided based on
their intramuscular Cr uptake [with mean changes in rest-
ing Cr + PCr of 29.5 mmol.kg-1 dw (n = 3), 14.9 mmol.kg-
1 dw (n = 5), and 5.1 mmol.kg-1 dw (n = 3), respectively].
They also observed that the "responders" had a higher per-
centage of type II muscle fibres and the greatest pre-load
muscle fibres cross-sectional area and fat free mass. The
same group showed an improvement in 1RM leg press
score following the Cr loading period. Whereas, the "non-Journal of the International Society of Sports Nutrition 2008, 5:14 http://www.jissn.com/content/5/1/14
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responders" group had exactly the opposite results than
the responders group following the 5-days Cr loading
period. It is plausible therefore that the lack of differences
in exercise performance observed in the present experi-
ment between the whole Cr and the Plc groups may be
due to a person-by-treatment different physiological
response to Cr supplementation. Furthermore, this may
be applied in several other studies which examined cen-
tral fatigue during prolonged exercise either in the heat or
in thermoneutral environment where pharmacological
treatment such as selective serotonin reuptake inhibitors
(SSRI) and/or other precursors and inhibitors of brain ser-
otonergic and dopaminergic systems were used as inter-
ventions. In a psychophysiological study for example,
where the differences between the "responders" and
"non-responders" to drug (brofaromine and fluvoxam-
ine) therapy were examined, it was suggested that heart
rate and blood pressure responsiveness to the drugs both
were different between the two groups, higher in the
"non-responders" than the "responders" to the drug [49].
Similarly, Kampf-Sherf et al. [50] examined the physiolog-
ical responses to SSRI treatment to depressed patients and
they suggested that only two third of patients with major
depression has shown a physiological responses to antide-
pressants such as SSRI. Consequently, the present results
may help partially explain the equivocal performance and
other physiological responses results reported in the liter-
ature following ergogenic aid supplements and/or drug
interventions of brain 5-HT and DA systems manipula-
tion.
Conclusion
In conclusion, the effectiveness of Cr to reduce thermal
stress per se and/or alter key modulators of brain 5-HT and
DA function may have contributed to the reduced effort
perception during exercise in the heat but not to that
extent in eliciting an enhancement of endurance perform-
ance in the whole Cr group. Consequently, the results pre-
sented here are consistent with a centrally-mediated
process of fatigue during strenuous exercise in the heat
either with or without using Cr supplementation. It is pos-
sible however, that Cr may improve performance only in
the "responders" to Cr; however, more studies are war-
ranted to justify this concept. The present results may also
suggest the demanding of the pre-experimental physio-
logical identification of the "responders" and "non-
responders" to Cr treatment. Otherwise, the possibility of
the type II statistical error may be augmented. Future stud-
ies need to investigate the direct effects of Cr supplemen-
tation on brain 5-HT and DA systems and their
association with central fatigue development during exer-
cise in the heat.
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